← Back to news

OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work

2026-10-21Industry news1 reads

The ChatGPT maker is folding Orchestra’s drug-program agents into Rosalind, its life sciences suite, betting AI can shave time off the decade-plus it takes to bring a medicine to patients.

Source: Decrypt

Curated by GTokenTool. All rights reserved by the original publisher. For informational purposes only — not investment advice.

More in this category

Tools for this